Genetic mechanism for the loss of PRAME in B cell lymphomas
Language English Country United States Media print
Document type Letter, Comment
PubMed
35838053
PubMed Central
PMC9282919
DOI
10.1172/jci160983
PII: 160983
Knihovny.cz E-resources
- Keywords
- Adaptive immunity, Immunoglobulins, Immunology,
- MeSH
- Antigens, Neoplasm * genetics MeSH
- Lymphoma, B-Cell * genetics MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Comment MeSH
- Names of Substances
- Antigens, Neoplasm * MeSH
- PRAME protein, human MeSH Browser
See more in PubMed
Takata K, et al. Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma. J Clin Invest. 2022;132(10):e145343. doi: 10.1172/JCI145343. PubMed DOI PMC
Bouska A, et al. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. Blood. 2017;30(16):1819–1831. PubMed PMC
Gunn SR, et al. Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene. Leuk Res. 2009;33(9):1276–1281. doi: 10.1016/j.leukres.2008.10.010. PubMed DOI
Mraz M, et al. The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus. Leuk Res. 2013;37(7):802–808. doi: 10.1016/j.leukres.2013.03.018. PubMed DOI
Stamatopoulos B, et al. The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia: results of a Multicenter Study. Clin Cancer Res. 2018;24(20):5048–5057. doi: 10.1158/1078-0432.CCR-18-0133. PubMed DOI
